Invion ( (AU:IVX) ) has shared an update.
Invion Limited has announced the quotation of 2,118,645 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code IVX. This move is part of previously announced transactions and is expected to enhance the company’s market presence and liquidity, potentially benefiting stakeholders by increasing the company’s visibility and access to capital.
More about Invion
Invion Limited operates in the biotechnology industry, focusing on developing innovative medical treatments. The company is primarily engaged in research and development of photodynamic therapy for cancer treatment, targeting significant unmet medical needs in oncology.
Average Trading Volume: 110
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $6.13M
For an in-depth examination of IVX stock, go to TipRanks’ Stock Analysis page.